Jasper Therapeutics Funding: $35M Raised, Series A (2019)
Jasper Therapeutics is based in Menlo Park, California. It has raised $35M in total funding. Latest round: Series A.
Jasper Therapeutics funding overview
Jasper Therapeutics is based in Menlo Park, California. Jasper Therapeutics has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2019. The round record for Jasper Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Abingworth LLP, Qiming Venture Partners USA. 2 distinct backers are named across the disclosed rounds.
Jasper Therapeutics at a glance
Total raised
$35M
Latest round
Series A
Latest round date
January 2019
Headquarters
Menlo Park, California
Notable investors
Abingworth LLP, Qiming Venture Partners USA
Frequently asked about Jasper Therapeutics funding
How much has Jasper Therapeutics raised?
Jasper Therapeutics has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Jasper Therapeutics?
Abingworth LLP, Qiming Venture Partners USA are named among the investors backing Jasper Therapeutics.
What was the latest Jasper Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2019.
Where is Jasper Therapeutics based?
Jasper Therapeutics is based in Menlo Park, California.
When did Jasper Therapeutics last raise?
The last disclosed Jasper Therapeutics round closed in January 2019 at Series A.
We update the Jasper Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Menlo Park and their backers are listed below.
